SHANGHAI — Chinese authorities have barred a British finance executive at the pharmaceutical giant GlaxoSmithKline from leaving the country while they carry out an investigation into bribery and corruption at the British company, the company confirmed on Wednesday.
Steve Nechelput, the company’s vice president for finance in China, has not been detained or prevented from traveling or working in China, and there is no indication that he is the focus of the investigation. But a person involved in the case said he was being prevented from leaving the country and had sought the advice of British consular officials here.
Read Full Article HERE
David Barboza, The New York Times via CHINA US Focus http://feedproxy.google.com/~r/ChinaUsFocus/~3/4b2bw8SWqx4/
No comments:
Post a Comment